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Özet
Amaç: Minimal invazif olarak kabul edilmesine rağmen perkütan nefrolito-
tomi (PCNL) halen belirgin komplikasyon riski taşımaktadır. Yeni çalışmalar, 
sepsis insidansının daha önce bildirilenlerden fazla olabileceğini ileri sürmek-
tedirler. Sistemik inflamatuar yanıt sendromu (SIRS), hayatı tehdit eden bir 
komplikasyondur ve hastaların bir kısmında bakteriyemili veya bakteriyemi-
siz görülebilmektedir, SIRS gelişme riski ile postoperatif ateş epizodu arasın-
daki ilişkinin aydınlatılması bu çalışmanın amacıdır. Gereç ve Yöntem: PCNL 
ameliyatı uygulanan 1646 yetişkin hastanın medikal kayıtları gözden geçiril-
miştir. Gerekli kriterleri taşıyan 1290 hasta çalışmaya alınmıştır. İstatistiksel 
analiz için gerekli çalışma değişkenleri tıbbi kayıtlardan elde edilmiştir. Bul-
gular: Taş yükü ile SIRS arasında anlamlı korelasyon bulunmaktadır (p<0,05) 
fakat ateş ile bulunmamaktadır. Hastaların komorbiditeleri tek başına ateş 
veya SIRS ilişkili değildir. Fakat ASA skoru 3 ve 4 ile SIRS istatistiksel kore-
lasyon göstermektedir (p<0,05). Karşılaşılan 288 komplikasyonun büyük ço-
ğunluğu Clavian 2. derece idi ve derecesi ≥2 komplikasyonlar hostpitalizas-
yon süresini artırmaktadır (p<0,05). Ameliyat süresi >120 dk., ateş ve SIRS ile 
korele olan tek operasyon değişkenidir. Kan kaybı >2 gr/dL (Δhemoglobin-Hb) 
ve Clavian 5 komplikasyonlar ateş ile istatistiksel anlamlı olarak koreledir. 
ASA skoru ≥3, ameliyat süresi >120 dk., ΔHb >2 gr/dL, taş boyutu ve Clavian 
5 komplikasyonlar ile SIRS gelişimi arasında istatistiksel anlamlı korelasyon 
bulunmaktadır. 181 (%14) hastada görülen , ateş epizodunun ölüme götüren 
SIRS’a ilerleme insidansı %1,6 olarak tespit edilmiştir. Tartışma: Postoperatif 
ateşin hayatı tehdit eden bir duruma ilerleme riski düşüktür. Fakat kan kaybı 
2 gr/dL’den fazla ve/veya ameliyat süresi 120 dakikadan fazla olması gibi di-
ğer SIRS kriterlerine sahip hastalara özel önem verilmelidir. Çok az hastada 
görülmesine rağmen çoklu organ yetmezliği ile ölüme neden olabilmektedir. 
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Abstract
Aim: Although accepted as minimally invasive, percutaneous nephrolithotomy 
(PCNL) still poses a significant risk of complications. Recent studies sug-
gest that the incidence of sepsis may be higher than previously reported. 
The systemic inflammatory response syndrome (SIRS) seen in the subset of 
patients with or without bacteremia, is a life threatening complication and 
the purpose of this study is to give an insight to the relation between a 
post-operative fever episode and the risk of developing SIRS. Material and 
Method: Medical files of 1646 adult patients to whom a PCNL operation was 
performed were reviewed. A total of 1290 patients fulfilled the needed cri-
teria and were included in the study. Study variables were recorded from the 
medical files for statistical analysis. Results: Stone burden had a statistically 
significant correlation with SIRS (p<0.05) but not with fever. Comorbidities 
of the patients alone did not have a correlation with fever or SIRS.  But 
ASA score 3 and 4 showed statistically significant correlations with SIRS 
(p<0.05). Majority of the 288 complications encountered were Clavian grade 
2 and grade ≥2 complications were seen to increase the hospitalization 
period (p<0.05). Operation time >120 min. was the only operative variable 
that had correlation with both fever and SIRS (p<0.05). Blood loss >2 g/dl 
(Δhaemoglobin-Hb) and Clavian 5 complications had statistically significant 
correlations with fever. ASA score ≥ 3, operation time >120 min., ΔHb >2 gr/
dl, stone size and Clavian 5 complications had statistically significant cor-
relations with the development of SIRS. The incidence of a fever episode, 
which was seen in 181 patients (14%), to progress to SIRS, which leaded to 
death, was found to be 1.6%. Discussion: Postoperative fever has a low risk 
of progressing to a life threatening condition. But special attention should 
be given to patients that also have the other SIRS criteria; blood loss more 
than 2 g/dl and/or operation time more than 120 minutes. Although only 
encountered in a small subset of patients, multiple organ dysfunctions can 
develop leading to death. 
Keywords
Percutaneous Nephrolithotomy; Systemic Inflammatory Response Syndrome; 
Fever
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Introduction
The routine management of renal stones has been changed 
over the past decades and open surgery is now rarely neces-
sary with the successful use of percutaneous nephrolithotomy 
(PCNL) for the treatment. Meanwhile, morbidity and mortality 
of renal stone disease and also of the treatment itself, has been 
dramatically reduced as the practice of PCNL has been perfect-
ed. Today, PCNL plays an integral role in managing renal stone 
disease. On the other hand, although accepted as minimally in-
vasive, it is an operation which still poses a significant risk of 
complications. Clavien system has been modified to grade these 
complications [1, 2]. 
Among the complications, febrile and infectious complications 
are commonly seen but sepsis has been reported to be rare. 
In the literature, sepsis rates of PCNL have been reported to 
be between 0.25 to 1.5% [3]. But more recent studies suggest 
that the incidence may be higher than previously reported [4, 
5]. Kadlec et al. [4] have reported 49 complications in their total 
cohort of 125 patients and 18 (14.4%) of these were febrile 
and infectious complications. Sepsis developed in four (3.2%) 
of these patients. Wang et al. [5] have reported a septic shock 
incidence of 2.4% among 420 patients who underwent a PCNL 
procedure.
The systemic inflammatory response syndrome (SIRS) seen in 
the subset of patients with (sepsis) or without bacteriemia is a 
life threatening complication. SIRS and sepsis are considered to 
be present in patients, who have two or more of the following 
criteria,
1- Body temperature lower than 36°C or higher than 38°C.
2- Heart rate greater than 90 beats/min.
3- Respiratory rate greater than 20 breaths/min or PaCO2 less 
than 32 mmHg.
4- White blood cell count (WBC) greater than 12x109/L or less 
than 4x109/L, or >10% immature (band) forms. 
These physiologic changes should represent an acute alteration 
from baseline in the absence of other known cause for such 
abnormalities [6]. 
Because the manifestations of sepsis are the same as those 
of SIRS, to diagnose the situation as sepsis, it should be de-
termined whether or not the symptoms are a part of the direct 
systemic response to the presence of an infectious process. The 
mechanism of SIRS is not completely understood but can cause 
organ dysfunction and death even after control of the infection 
[7]. The question ‘should a post-operative febrile episode seen 
during the early postoperative period after PCNL be treated as 
a grade I complication and followed so or as a grade II compli-
cation and treated more aggressively keeping in mind that it 
might be a component of SIRS and may progress to grade IV 
or V?’ is still not answered. This single institution retrospective 
chart review aims to provide an insight to this question. 
Material and Method
Medical files of 1646 adult patients to whom a PCNL operation 
was performed between 8/2002 and 5/2012 were reviewed. Pa-
tients with confounding factors that would have predisposed to 
urinary tract infection (UTI) or urosepsis were excluded from the 
study. Exclusion criteria included patients with a stent, nephros-
tomy tube or indwelling catheter, fever before surgery, patients 
with active UTI, internal problems that would affect SIRS cri-
teria, contralateral renal or ureteric stone disease, second look 
PCNL and same session bilateral PCNL operations.  
Data recorded from the medical files included: age, gender, 
stone size, stone location, presence of hydronephrosis, other 
concomitant disease, previous shock wave lithotripsy or renal 
surgery history, American Society of Anesthesiologists (ASA) 
score, subcostal or intercostal entry, number of access tracts 
made during the operation, dilatation type (Amplatz dilators/
balloon dilatation), operation time, blood transfusion, complica-
tions, hospitalization time, residual stone status, pre-operative 
haemoglobin (Hb) and WBC, post-operative Hb and WBC, post-
operative maximum and minimum body temperatures, post-
operative maximum heart and respiratory rates, post-operative 
renal and blood culture results.
The kidney stones were diagnosed by intravenous pyelography 
and/or computerized tomography (CT). Stone size was measured 
as the surface area calculated according to the EUA guidelines 
using the two greatest vertical and horizontal dimensional mea-
sures seen on a plain x-ray of the kidney-ureter-bladder (KUB) 
[8]. Stones filling the renal pelvis and all of the calyces were de-
fined as staghorn calculi and the area of each stone part located 
in the calyces and the pelvis was calculated separately and then 
added. The size of radiolucent stones were calculated by the 
same way but by the dimensions obtained from non-contrast 
computed tomography images.  
Operation time was derived from the anesthesia chart and de-
fined as the time elapsed in minutes from the induction of anes-
thesia until the insertion of nephrostomy catheter. The patients 
were grouped into 4 groups (30-60 min, 61-90 min, 91-120 min, 
and >120 min). The difference of haemoglobin (ΔHb) was cal-
culated by subtracting the hemoglobin value after surgery from 
the value obtained within a week before surgery. The patients 
were grouped into 5 groups (0-0.5, 0.6-1, 1.1-1.5, 1.6-2 and >2 
gr/dl).
The patients were evaluated using a KUB performed on the 
morning after the procedure and a CT performed 1 month af-
ter the operation for the follow-up. Postoperative outcome was 
evaluated by post-operative CT and patients lacking it were 
also excluded from the study. The residual stone status was 
evaluated in three categories; stone free (SF), clinically insig-
nificant residual fragments (CIRF, residual fragments smaller 
than 4 mm) and clinically significant residual fragments (CSRF, 
residual fragments larger than 4 mm). Success rate was defined 
as the sum of SF and CIRF.
The type of complication encountered was noted and then clas-
sified according to the modified Clavien System [1]. For any pa-
tient, only the complication of highest grade was analyzed. Hos-
pitalization time was defined as the number of days the patient 
spent at the hospital starting from the day of surgery. 
According to the elective endoscopic operation preparation pro-
tocol of our clinic, all patients included in the study had a pre-
operative urine culture and were treated pre-operatively accord-
ing to the antibiotic sensitivity tests. More than 105 organisms 
per milliliter detected on a urine culture were used to define an 
infection and the operations were performed only after achiev-
ing a negative urine culture. Again, according to the protocol, all 
patients received peri-operative prophylactic antibiotic treat-
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ment before surgery on arrival at the operation theatre with an 
intravenous administration of 1 g Cephazolin, a first-generation 
cephalosporin antibiotic and the antibiotic treatment was con-
tinued post-operatively with intravenous Ciprofloxacin 200 mg, 
bid, during the first post-operative day (POD). If post-operative 
fever >38°C was encountered, urine cultures from the nephros-
tomy catheter and two blood cultures were obtained and the 
intravenous antibiotic treatment was continued. The treatment 
was later changed according to the antibiotic sensitivity of the 
cultures. Otherwise, in the case of an uneventful post-operative 
period, this treatment was continued with per os Ciprofloxacin 
twice a day for 5 days starting from the post-operative day 2. 
Patients with known drug allergies, patients under age 18 or 
with renal insufficiency are exceptions for the above-mentioned 
peri-operative and post-operative antibiotic treatments and for 
the standardization of the treatment, these patients were not 
included in the study.
Patients that did not have medical data of the above mentioned 
study variables were excluded from the study. A total of 1290 
patients fulfilled the needed criteria and were included in the 
study.
Operations: All of the operations were performed in a single 
center under general anesthesia. After ureteral catheter inser-
tion in the lithotomy position, the patients were tilted to prone 
position. The pyelocalyceal system was approached with the 
insertion of an 18-gauge Chiba needle under fluoroscopic guid-
ance. Tract dilation was achieved either via Amplatz or a high 
pressure balloon dilator NephroMaxTM (Boston scientific) after 
placement of a safety guide-wire in place. At the end of the di-
lation, a 30F renal sheath (Microvasive, Natick, Massachusetts) 
was placed and rigid nephroscopy was performed. A pneumatic 
lithotripter was used for stone fragmentation. The stone frag-
ments were mechanically extracted and a nephrostomy catheter 
(14-20F) was placed at the end of the operation. The nephros-
tomy catheter was withdrawn following an antegrade pyelog-
raphy which was performed after the gross hematuria cleared. 
Abandoned procedures due to failure to obtain access or bleed-
ing at the time of dilation were not included in the study.
Statistical analysis: Statistical analysis of data was performed 
with Statistical Package for Social Sciences (SPSS) 15.0 for 
Windows and in addition to descriptive statistical methods 
(mean, standard deviation), Chi-square and Mann-Whitney tests 
were used for qualitative and numerical data, as appropriate. 
P values <0.05 were considered to be statistically significant. 
Results
Table 1 shows the demographic and clinical characteristics of 
the patients and stones. Patient age distribution was 48.1 ± 
15.7 years (range 18-85 years). Stone burden had a statistically 
significant correlation with SIRS (p<0.05) but not with fever. 
Comorbidities of the patients alone did not have a significant 
correlation with fever or SIRS.  But ASA score 3 and 4 showed 
significant correlations with SIRS (p<0.05). 
Operation time >120 min. was the only operative variable that 
had correlation with both fever and SIRS (Table 2). The corre-
lation was statistically significant for fever and also for SIRS 
(p<0.05).
Most of the fever episodes were seen during the first or second 
POD and other than operation time, ΔHb >2 g/dl and Clavian 5 
complications had statistically significant correlations with fe-
ver (Table 3). ASA score ≥ 3, operation time >120 min., ΔHb >2 
g/dl, stone size and Clavian 5 complications were the param-
eters which had statistically significant correlations with the 
development of SIRS. 
A total of 288 complications (22.3%) were encountered and 
the majority was Clavian grade 2 (Table 3). Clavian grade ≥2 
complications were seen to increase the hospitalization period 
(p<0.05). Bleeding, urine leakage, clot or small fragments caus-
ing obstruction, renal pelvic perforation, deranged renal func-
tion, fever, pulmonary edema, ileus, pneumothorax, hydrotho-
rax, colon perforation, sepsis, perirenal abscess, arterioveneous 
fistula, pulmonary embolism and death were the complications 
encountered. Two of the pulmonary embolisms seen in the study 
Table 1. Pre-operative clinical data of the patients
Variable Value P value
(fever)
P value 
(SIRS)
Gender (n/%)
     Male 
     Female 
737/57%
553/43%
0.65
0.57
0.83
0.66
Patient age (years)
     Mean ± SD
     Range
48.1±15.7
18-85
0.80 0.59
 Main comorbidities (n/%)
     Diabetes Mellitus
     Cardiovascular disease     
218/17%
347/27%
0.23
0.29
0.57
0.83
Stone burden (mm2/renal unit)
     Mean ± SD  426.4±285.9 0.11 P<0.05*
Hydronephrosis (n/%)
     Nil
     Mild     
     Moderate-Severe
127/10%
481/37%
682/53%
0.63
0.46
0.48
0.40
0.67
0.44
Stone location 
     Renal pelvis
     Lower pole calyceal
     Middle pole calyceal 
     Upper pole calyceal 
     Stones in multiple calyces
     Staghorn calculus
426/33%
233/18%
39/3%
64/5%
322/25%
206/16%
0.7
0.17
0.36
0.62
0.23
0.14
0.82
0.38
0.24
0.12
0.32
0.28
ASA score (n/%)
     1
     2
     3
     4   
326/25%
802/62%
161/12%
1/<1%
0.34
0.26
0.78
0.46
0.65
0.13
P<0.05*
P<0.05*
Table 2. Operative data of the patients
Variable Value P value 
(fever)
P value 
(SIRS)
Operation time (min)
     Mean ± SD
     Range
                   30-60 min (n/%)
                   60-90 min (n/%)
                   90-120 min (n/%)
                   >120 min (n/%)
80,7±43,7
30-240
246/19%
362/28%
497/39%
185/14%
0.36
0.18
0.17
P<0.05*
0.33
0.14
0.11
P<0.05*
Number of percutaneous tracts (n/%)
     1
     2
     3
947/73%
291/23%
52/4%
0.56
0.33
0.12
0.23
0.39
0.25
Percutaneous access (n/%)
     Subcostal
     Intercostal
1193/92%
97/8%
0.87
0.92
0.74
0.42
Dilation (n/%)
     Nephromax
     Amplatz
1102/69%
488/31%
0.13
0.45
0.30
0.32
Intra-operative blood transfusion (n/%) 52 (4%) 0.11 0.20
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group were managed without the need of an intensive care unit 
(ICU) management and were classified as grade 2 complica-
tions. The remaining two were treated in the ICU and classified 
as Grade 4a. One of the three patients who died (0.2%, Cla-
vian 5) had a staghorn stone disease and an ASA score 4 (renal 
failure, diabetes mellitus and hypertension). The operation time 
was 140 min. and was stone free at the end of the operation. 
The operation was uneventful and was performed through lower 
and middle calyx entries. But massive bleeding occurred after 
the renal sheath was removed and was treated with emboliza-
tion of the bleeding lower pole accessory artery.  The other two 
patients also had large stones, operation times > 120 min. and 
Hb loss more than 2 g/dl. But embolization was not performed 
and these patients were followed with blood transfusions. In 
all of the three patients, bleeding stopped but persistent fe-
ver was encountered in the post-operative period. They had all 
four of the SIRS criteria but the nephrostomy and blood cul-
tures showed no microorganism growth. Their conditions dete-
riorated in spite of the administered broad spectrum antibiotics 
and medical treatment.  Eventually multiple organ failure (MOF) 
developed leading to death.  
The most common isolated microorganism from the renal pelvis 
cultures was Escherichia Coli (47%). Coagulase (-) staphylococ-
cus (29%), Enterococcus (13%), Proteus (4%), Klebsiella (3%), 
Acinobacter (3%) and ≥2 microorganisms (1%) were the other 
microorganisms encountered. Blood cultures showed positivity 
in 48 patients and the isolated microorganisms were Escherich-
ia Coli (44%), Enterococcus (29%) and Staphylococcus (27%). 
But neither the renal pelvis nor the blood cultures had signifi-
cant correlations with fever (p=0.56 and p=0.15, respectively) or 
SIRS (p=0.31 and p=0.17, respectively). When investigated fur-
ther, post-operative leukocytosis alone, did not predict a febrile 
episode or a positive culture (p= 0.23 and p= 0.28, respectively). 
The incidence of a fever episode, which was seen in 181 pa-
tients (14%), to progress to SIRS which leaded to death, was 
found to be 1.6%.
Discussion
The pathophysiology of SIRS and the events that lead to MOF are 
poorly understood. Studies have shown that the development of 
SIRS is associated with immunosuppression and a dysregulated 
inflammatory response in which an excessive generation of po-
Table 3. Post-operative data of the patients
Variable Value P value 
(fever)
P value 
(SIRS)
Duration of nephrostomy catheter (days)
     Mean ± SD
     Range
2.4±1.06
1-14
0.75 0.49
ΔHb (g/dl)
     Mean ± SD
              0-0.5 gr/dl (n/%)
              0.6-1 gr/dl (n/%)
              1.1-1.5 gr/dl (n/%)
              1.6-2 gr/dl (n/%)
              > 2 gr/dl (n/%)
-2.5±1.02
90/7%
460/36%
165/13%
262/20%
313/24%
0.34
0.17
0.42
0.08
P<0.05*
0.23
0.51
0.21
0.11
P<0.05*
Post-operative WBC>12x109/L,<4x109,
>10% immature forms (n/%)
645/50% 0.23 0.19
Post-operative respiratory rate >20/min, 
PaCO2<32 mmHg (n/%)
606/47% 0.89 0.91
Post-operative heart rate >90 beats/min 
(n/%)
451/35% 0.73 0.22
Post-operative body temperature >38°C 
or <36°C (n/%)
181/14% - 0.15
Patients fulfilling SIRS criteria (n/%)
     2 variable
     3 variable
     4 variable
374/29%
181/14%
129/10%
64/5%
0.21
0.16
P<0.05*
-
-
-
Post-operative
     positive urine/blood culture (n/%)
     positive urine culture
     positive blood culture  
Post-operative positive urine/blood cul-
ture in the post-operative fever group 
61/5%
48/4%
36/3%
61/34%
0.41
0.56
0.15
0.12
0.67
0.31
0.17
0.26
Complication (n/%)
     Clavian 1
     Clavian 2
     Clavian 3a
     Clavian 3b
     Clavian 4a
     Clavian 4b
     Clavian 5
288/22.3%
84/6.5 %
145/11.2%
32/2.5%
21/1.6%
3/0.2%
-
3/0.2%
0.36
0.14
0.53
0.33
0.13
-
P<0.05*
0.22
0.58
0.15
0.43
0.21
-
P<0.05*
Post-operative blood transfusion (n/%) 39 (3%) 0.11 0.08
Residual stone status (n/%)
     SF
     CIRF
     CSRF     
931/72%
149/12%
210/16%
0.24
0.29
0.15
0.17
0.11
0.29
Success rate  (SF+CIRF) (%) 84% - -
Table 4. Post-operative data of the patients
Variable Value P value 
(fever)
P value 
(SIRS)
Duration of nephrostomy catheter (days)
     Mean ± SD
     Range
2.4±1.06
1-14
0.75 0.49
ΔHg (g/dl)
     Mean ± SD
              0-0.5 gr/dl (n/%)
              0.6-1 gr/dl (n/%)
              1.1-1.5 gr/dl (n/%)
              1.6-2 gr/dl (n/%)
              > 2 gr/dl (n/%)
-2.5±1.02
90/7%
460/36%
165/13%
262/20%
313/24%
0.34
0.17
0.42
0.08
P<0.05*
0.23
0.51
0.21
0.11
P<0.05*
Post-operative WBC>12x109/L,<4x109,
>10% immature forms (n/%)
645/50% 0.23 0.19
Post-operative respiratory rate >20/min, 
PaCO2<32 mmHg (n/%)
606/47% 0.89 0.91
Post-operative heart rate >90 beats/min 
(n/%)
451/35% 0.73 0.22
Post-operative body temperature >38°C 
or <36°C (n/%)
181/14% - 0.15
Patients fulfilling SIRS criteria (n/%)
     2 variable
     3 variable
     4 variable
374/29%
181/14%
129/10%
64/5%
0.21
0.16
P<0.05*
-
-
-
Post-operative
     positive urine/blood culture (n/%)
     positive urine culture
     positive blood culture  
Post-operative positive urine/blood cul-
ture in the post-operative fever group
61/5%
48/4%
36/3%
61/34%
0.41
0.56
0.15
0.12
0.67
0.31
0.17
0.26
Complication (n/%)
     Clavian 1
     Clavian 2
     Clavian 3a
     Clavian 3b
     Clavian 4a
     Clavian 4b
     Clavian 5
288/22.3%
84/6.5 %
145/11.2%
32/2.5%
21/1.6%
3/0.2%
-
3/0.2%
0.36
0.14
0.53
0.33
0.13
-
P<0.05*
0.22
0.58
0.15
0.43
0.21
-
P<0.05*
Post-operative blood transfusion (n/%) 39 (3%) 0.11 0.08
Residual stone status (n/%)
     SF
     CIRF
     CSRF    
931/72%
149/12%
210/16%
0.24
0.29
0.15
0.17
0.11
0.29
Success rate  (SF+CIRF) (%) 84% - -
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tent proinflammatory cytokines and chemokines is present [9]. 
During sepsis, there is a shift in the redox (oxidation-reduction) 
balance toward the oxidant state. This seems to intensify the 
development of SIRS, MOF and septic shock suggesting that 
the regulation of inflammatory response is defective [10]. But 
many other factors have also been postulated to trigger SIRS, 
including products released from bacteria (lipoteichoic acid and 
bacterial lipopolysaccharide) as well as products from damaged 
cells released after ischemia-reperfusion or after blunt trauma, 
in which no infectious agent is involved [7].  The results of this 
study corroborate the hypothesis that probably a non-infectious 
mechanism is involved in the development of SIRS encountered 
after PCNL.
In a previously reported study by Chen et al. [11], the incidence 
of SIRS in 209 patients who underwent PCNL was reported as 
23.4%. Number of tracts, blood transfusion, stone size and pres-
ence of pyelocaliectasis were identified as risk factors for the 
development of SIRS. Another study by Mariappan et al. inves-
tigated 52 patients with stones ≥ 2cm and dilated pelvicalyceal 
systems to whom 1 week per os ciprofloxacin treatment was 
given as an extended antibiotic prophylaxis [12]. They found a 
7% SIRS rate in these patients compared to 18% SIRS in the 
control group. 
During PCNL, the decision to perform multiple tracts when 
needed, depends mostly on whether there is bleeding or not. 
The results of this study showed correlation of SIRS with nei-
ther the number of tracts nor blood transfusions. ASA score ≥ 3, 
operation time >120 min, ΔHb >2 g/dl, stone size and Clavian 5 
complications were the parameters which had statistically sig-
nificant correlation with SIRS. Operation time >120 min, ΔHb 
>2 g/dl and Clavian 5 complications were the parameters which 
had statistically significant association with fever. ΔHb more 
than 2 g/dl and an operation time more than 120 min. showed 
a statistical significant correlation both with fever and also with 
SIRS. Overt causes such as post-operative pain and blood trans-
fusion can also cause some of the SIRS criteria such as tachy-
cardia and fever and might have had an impact on the relatively 
high SIRS rate (29%) of this study. Due to the retrospective 
nature of the study, patients with tachycardia due to pain and 
patients with tachycardia as a component of SIRS could not be 
differentiated, but intra-operative and/or post-operative blood 
transfusion had no statistically significant correlation with fever 
and also none with SIRS. Post-operative leukocytosis alone did 
not predict a febrile episode or a positive culture. 
Endoscopic instrumentation in the presence of stones can in-
duce bacteremia and septic shock [5]. Previously, numerous 
studies have been made in hope to be able to predict sepsis 
with pre-operative bladder urine culture, renal pelvis urine or 
stone culture.  The incidence of post-operative bacteriuria in 
patients undergoing PCNL without prophylactic antibiotics has 
been reported to be 20% and stone culture positivity as 35% 
[13]. Furthermore, in the same study, it has been shown that 
infection in the upper tracts (either renal pelvic urine or stones) 
has four times the risk of resulting in urosepsis after PCNL, es-
pecially with large stones (≥20 mm) or in dilated pelvicalyceal 
systems. Rao et al. [14] have reported a statistically significant 
association between pre-operative bacteriuria and the develop-
ment of post-operative bacteremia. Their results showed bac-
teremia in 37% of patients with a positive pre-operative urine 
culture and 8% in those with a negative urine culture. But con-
troversially, Fowler JE [15] has reported a 77.3% incidence rate 
of infected stone culture and found that only 12.5% of these 
patients have a positive urine culture obtained from the bladder. 
Other studies have also shown that pre-operative bladder urine 
is not a good predictor for post-operative bacteriuria or bacte-
remia and stone or renal pelvic urine cultures are better [13]. 
Fever incidence has been reported as 28.8% in a study in which 
the patients had negative urine cultures before the operation 
and who were treated with prophylactic antibiotics [16]. 
On the other hand, in this study group, when compared to these 
previous studies, although SIRS was encountered slightly more 
frequently, fever and positive cultures were seen less and posi-
tive cultures had no statistical significant correlation with SIRS. 
Patients fulfilling the SIRS criteria were 29% of the total 1290 
patients. Fever was seen in 14% and positive urine and/or blood 
cultures were seen in only 5% (sepsis) of the patients. But it 
should be noted that post-operative cultures were only obtained 
from the patients who developed fever in the postoperative pe-
riod.  Positive cultures were seen in 34% of this patient group 
who had at least one post-operative fever episode. These re-
sults might be affected by the strict preparation protocol not 
allowing the operation to be performed until a negative urine 
culture is obtained, although it might be accepted as an over-
treatment, the prolonged antibiotic use which was administered 
according to our protocol or by the culture results that might 
have been altered by the prophylactic antibiotics used.
Seitz et al. [17] have reported a 23.3% complication rate in their 
group of PCNL patients. When the literature is reviewed most of 
the complications encountered after a PCNL operation are low 
grade complications. Especially Clavian 1 and 2 complications 
have differences between institutions due to different antibiotic 
protocols. In an institution where antibiotics are administered 
post-operatively as a routine treatment are not accepted as a 
deviation from the normal pharmacological treatment. But in 
another institution where no post-operative antibiotics are rou-
tinely used, the same antibiotic treatment is graded as Clavian 
1. Post-operative antibiotics were used routinely in this study 
group and Clavian 1 complications were encountered less than 
Clavian 2 complications (6.5% and 11.2%, respectively). The 
retrospective nature of the study may have limited the ability 
to capture some of the low grade complications. Again, in an 
institution where radiological interventions are regularly and 
successfully performed, a complication might be treated by 
interventional radiology and general anesthesia might not be 
needed (Clavian 3a). But in another institution, the same com-
plication may have to be treated by surgery under general an-
esthesia (Clavian 3b). Under the shadow of these weak points 
of the Clavian system, complications were seen in 22.3% of the 
patients and most of them were low grade (smaller than Clavian 
3a) and Clavian 3a and higher complications were seen in 4.5% 
of the patients. 
All of the SIRS criteria including fever were present in all, but 
bacteriuria (renal pelvis) and/or bacteremia was seen in none 
of the 3 patients who died due to MOF suggesting that other 
mechanisms enrolled in SIRS play role in the process. Support-
ing this, Martin et al. [18] have reported bacteremia in only 50% 
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of their septic patient group.   The results of this study suggest 
that a long traumatic operation for a large stone, causing a sig-
nificant blood loss in a patient with co-morbidities that affect 
his/her life (ASA≥3) might trigger a non-bacterial mechanism 
of SIRS. The renal trauma caused by PCNL might be the reason 
of the excessive generation of pro-inflammatory cytokines and 
chemokines causing a dysregulated inflammatory response or 
a mechanism aggravated by a suppressed immune response 
might be involved [9, 10]. Further studies are needed to clarify 
the mechanism involved.
Conclusions  
Fever which is mostly seen on the first or second post-operative 
days has a low risk of progressing to a life threatening condi-
tion. But special attention should be given to patients that also 
have all of the other SIRS criteria, big stone burden, blood loss 
more than 2 g/dl and/or an operation time more than 120 min-
utes. Although only encountered in a small subset of patients 
(1.6% of the fever group), even if the patient has a sterile pre-
operative urine culture and is also under antibiotic treatment, 
multiple organ failure can develop leading to death. 
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